Loading clinical trials...
Loading clinical trials...
A Phase IV Study of Corticosteroids As Prophylaxis for Infusion-Related Adverse Events to Mylotarg® in Patients With Acute Myelogenous Leukemia (AML)
Conditions
Interventions
Mylotarg
Start Date
April 1, 2002
Completion Date
January 1, 2004
Last Updated
July 29, 2009
NCT07184489
NCT06905119
NCT02158858
NCT01756118
NCT00201240
NCT00449319
Lead Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions